SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-018219
Filing Date
2020-03-11
Accepted
2020-03-11 17:53:46
Documents
2
Period of Report
2020-03-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2212
2 EX-24 DOCUMENT attachment1.htm EX-24 7215
  Complete submission text file 0001209191-20-018219.txt   11014
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLTZMAN ST, WEIZMANN SCIENCE PARK REHOVOT L3 7670402
Business Address
Wiley Matthew T. (Reporting) CIK: 0001759703 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38356 | Film No.: 20706483